399 related articles for article (PubMed ID: 33444330)
1. Polygenic risk scores in cardiovascular risk prediction: A cohort study and modelling analyses.
Sun L; Pennells L; Kaptoge S; Nelson CP; Ritchie SC; Abraham G; Arnold M; Bell S; Bolton T; Burgess S; Dudbridge F; Guo Q; Sofianopoulou E; Stevens D; Thompson JR; Butterworth AS; Wood A; Danesh J; Samani NJ; Inouye M; Di Angelantonio E
PLoS Med; 2021 Jan; 18(1):e1003498. PubMed ID: 33444330
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular Disease Risk Assessment Using Traditional Risk Factors and Polygenic Risk Scores in the Million Veteran Program.
Vassy JL; Posner DC; Ho YL; Gagnon DR; Galloway A; Tanukonda V; Houghton SC; Madduri RK; McMahon BH; Tsao PS; Damrauer SM; O'Donnell CJ; Assimes TL; Casas JP; Gaziano JM; Pencina MJ; Sun YV; Cho K; Wilson PWF
JAMA Cardiol; 2023 Jun; 8(6):564-574. PubMed ID: 37133828
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein, fibrinogen, and cardiovascular disease prediction.
; Kaptoge S; Di Angelantonio E; Pennells L; Wood AM; White IR; Gao P; Walker M; Thompson A; Sarwar N; Caslake M; Butterworth AS; Amouyel P; Assmann G; Bakker SJ; Barr EL; Barrett-Connor E; Benjamin EJ; Björkelund C; Brenner H; Brunner E; Clarke R; Cooper JA; Cremer P; Cushman M; Dagenais GR; D'Agostino RB; Dankner R; Davey-Smith G; Deeg D; Dekker JM; Engström G; Folsom AR; Fowkes FG; Gallacher J; Gaziano JM; Giampaoli S; Gillum RF; Hofman A; Howard BV; Ingelsson E; Iso H; Jørgensen T; Kiechl S; Kitamura A; Kiyohara Y; Koenig W; Kromhout D; Kuller LH; Lawlor DA; Meade TW; Nissinen A; Nordestgaard BG; Onat A; Panagiotakos DB; Psaty BM; Rodriguez B; Rosengren A; Salomaa V; Kauhanen J; Salonen JT; Shaffer JA; Shea S; Ford I; Stehouwer CD; Strandberg TE; Tipping RW; Tosetto A; Wassertheil-Smoller S; Wennberg P; Westendorp RG; Whincup PH; Wilhelmsen L; Woodward M; Lowe GD; Wareham NJ; Khaw KT; Sattar N; Packard CJ; Gudnason V; Ridker PM; Pepys MB; Thompson SG; Danesh J
N Engl J Med; 2012 Oct; 367(14):1310-20. PubMed ID: 23034020
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease.
Welsh C; Celis-Morales CA; Brown R; Mackay DF; Lewsey J; Mark PB; Gray SR; Ferguson LD; Anderson JJ; Lyall DM; Cleland JG; Jhund PS; Gill JMR; Pell JP; Sattar N; Welsh P
Circulation; 2019 Aug; 140(7):542-552. PubMed ID: 31216866
[TBL] [Abstract][Full Text] [Related]
5. Lipid-related markers and cardiovascular disease prediction.
; Di Angelantonio E; Gao P; Pennells L; Kaptoge S; Caslake M; Thompson A; Butterworth AS; Sarwar N; Wormser D; Saleheen D; Ballantyne CM; Psaty BM; Sundström J; Ridker PM; Nagel D; Gillum RF; Ford I; Ducimetiere P; Kiechl S; Koenig W; Dullaart RP; Assmann G; D'Agostino RB; Dagenais GR; Cooper JA; Kromhout D; Onat A; Tipping RW; Gómez-de-la-Cámara A; Rosengren A; Sutherland SE; Gallacher J; Fowkes FG; Casiglia E; Hofman A; Salomaa V; Barrett-Connor E; Clarke R; Brunner E; Jukema JW; Simons LA; Sandhu M; Wareham NJ; Khaw KT; Kauhanen J; Salonen JT; Howard WJ; Nordestgaard BG; Wood AM; Thompson SG; Boekholdt SM; Sattar N; Packard C; Gudnason V; Danesh J
JAMA; 2012 Jun; 307(23):2499-506. PubMed ID: 22797450
[TBL] [Abstract][Full Text] [Related]
6. Improving 10-year cardiovascular risk prediction in apparently healthy people: flexible addition of risk modifiers on top of SCORE2.
Hageman SHJ; Petitjaen C; Pennells L; Kaptoge S; Pajouheshnia R; Tillmann T; Blaha MJ; McClelland RL; Matsushita K; Nambi V; Klungel OH; Souverein PC; van der Schouw YT; Verschuren WMM; Lehmann N; Erbel R; Jöckel KH; Di Angelantonio E; Visseren FLJ; Dorresteijn JAN
Eur J Prev Cardiol; 2023 Oct; 30(15):1705-1714. PubMed ID: 37264679
[TBL] [Abstract][Full Text] [Related]
7. Polygenic Risk Scores Predict Hypertension Onset and Cardiovascular Risk.
Vaura F; Kauko A; Suvila K; Havulinna AS; Mars N; Salomaa V; FinnGen ; Cheng S; Niiranen T
Hypertension; 2021 Apr; 77(4):1119-1127. PubMed ID: 33611940
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular disease risk prediction using automated machine learning: A prospective study of 423,604 UK Biobank participants.
Alaa AM; Bolton T; Di Angelantonio E; Rudd JHF; van der Schaar M
PLoS One; 2019; 14(5):e0213653. PubMed ID: 31091238
[TBL] [Abstract][Full Text] [Related]
9. Integration of a polygenic score into guideline-recommended prediction of cardiovascular disease.
Li L; Pang S; Starnecker F; Mueller-Myhsok B; Schunkert H
Eur Heart J; 2024 May; 45(20):1843-1852. PubMed ID: 38551411
[TBL] [Abstract][Full Text] [Related]
10. Incremental value of risk factor variability for cardiovascular risk prediction in individuals with type 2 diabetes: results from UK primary care electronic health records.
Xu Z; Arnold M; Sun L; Stevens D; Chung R; Ip S; Barrett J; Kaptoge S; Pennells L; Di Angelantonio E; Wood AM
Int J Epidemiol; 2022 Dec; 51(6):1813-1823. PubMed ID: 35776101
[TBL] [Abstract][Full Text] [Related]
11. Associations of cardiometabolic polygenic risk scores with cardiovascular disease in African Americans.
Tsegaselassie W; Jian Y; Berhanu GG; Tianyuan L; April M; Tali E; Fasil TA; Timothy TA; Jordana C; Marguerite IR; Robert SM; Michael VW; Kristine Y; Myriam F; Donald LM; Mario S; Daichi S; Yuichiro Y; Paul M; Adam B
Res Sq; 2023 Aug; ():. PubMed ID: 37693576
[TBL] [Abstract][Full Text] [Related]
12. Glycated hemoglobin measurement and prediction of cardiovascular disease.
; Di Angelantonio E; Gao P; Khan H; Butterworth AS; Wormser D; Kaptoge S; Kondapally Seshasai SR; Thompson A; Sarwar N; Willeit P; Ridker PM; Barr EL; Khaw KT; Psaty BM; Brenner H; Balkau B; Dekker JM; Lawlor DA; Daimon M; Willeit J; Njølstad I; Nissinen A; Brunner EJ; Kuller LH; Price JF; Sundström J; Knuiman MW; Feskens EJ; Verschuren WM; Wald N; Bakker SJ; Whincup PH; Ford I; Goldbourt U; Gómez-de-la-Cámara A; Gallacher J; Simons LA; Rosengren A; Sutherland SE; Björkelund C; Blazer DG; Wassertheil-Smoller S; Onat A; Marín Ibañez A; Casiglia E; Jukema JW; Simpson LM; Giampaoli S; Nordestgaard BG; Selmer R; Wennberg P; Kauhanen J; Salonen JT; Dankner R; Barrett-Connor E; Kavousi M; Gudnason V; Evans D; Wallace RB; Cushman M; D'Agostino RB; Umans JG; Kiyohara Y; Nakagawa H; Sato S; Gillum RF; Folsom AR; van der Schouw YT; Moons KG; Griffin SJ; Sattar N; Wareham NJ; Selvin E; Thompson SG; Danesh J
JAMA; 2014 Mar; 311(12):1225-33. PubMed ID: 24668104
[TBL] [Abstract][Full Text] [Related]
13. Lifetime and 10-year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE-T1D model.
Helmink MAG; Hageman SHJ; Eliasson B; Sattar N; Visseren FLJ; Dorresteijn JAN; Harris K; Peters SAE; Woodward M; Szentkúti P; Højlund K; Henriksen JE; Sørensen HT; Serné EH; van Sloten TT; Thomsen RW; Westerink J
Diabetes Obes Metab; 2024 Jun; 26(6):2229-2238. PubMed ID: 38456579
[TBL] [Abstract][Full Text] [Related]
14. External validation of the QLifetime cardiovascular risk prediction tool: population cohort study.
Livingstone S; Morales DR; Fleuriot J; Donnan PT; Guthrie B
BMC Cardiovasc Disord; 2023 Apr; 23(1):194. PubMed ID: 37061672
[TBL] [Abstract][Full Text] [Related]
15. Combining European and U.S. risk prediction models with polygenic risk scores to refine cardiovascular prevention: the CoLaus|PsyCoLaus Study.
de La Harpe R; Thorball CW; Redin C; Fournier S; Müller O; Strambo D; Michel P; Vollenweider P; Marques-Vidal P; Fellay J; Vaucher J
Eur J Prev Cardiol; 2023 May; 30(7):561-571. PubMed ID: 36652418
[TBL] [Abstract][Full Text] [Related]
16. Validation of a deep-learning-based retinal biomarker (Reti-CVD) in the prediction of cardiovascular disease: data from UK Biobank.
Tseng RMWW; Rim TH; Shantsila E; Yi JK; Park S; Kim SS; Lee CJ; Thakur S; Nusinovici S; Peng Q; Kim H; Lee G; Yu M; Tham YC; Bakhai A; Leeson P; Lip GYH; Wong TY; Cheng CY
BMC Med; 2023 Jan; 21(1):28. PubMed ID: 36691041
[TBL] [Abstract][Full Text] [Related]
17. Circulating gamma glutamyltransferase and prediction of cardiovascular disease.
Kunutsor SK; Bakker SJ; Kootstra-Ros JE; Gansevoort RT; Dullaart RP
Atherosclerosis; 2015 Feb; 238(2):356-64. PubMed ID: 25555268
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular risk prediction models for people with severe mental illness: results from the prediction and management of cardiovascular risk in people with severe mental illnesses (PRIMROSE) research program.
Osborn DP; Hardoon S; Omar RZ; Holt RI; King M; Larsen J; Marston L; Morris RW; Nazareth I; Walters K; Petersen I
JAMA Psychiatry; 2015 Feb; 72(2):143-51. PubMed ID: 25536289
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
